Abstract
We characterized the binding of [125I]epidepride to dopamine D2-like and D3-like receptors in tissue sections of human striatum. The competition for binding of [125I]epidepride by domperidone, quinpirole, and 7-hydroxy-N,N-di(1-propyl)-2-aminotetralin (7-OH-DPAT) was best fit by assuming one site in the caudate but two sites in nucleus accumbens. Guanosine 5'-[beta, gamma-imido]triphosphate showed a large modulatory influence in agonist inhibition of [125I]epidepride binding in caudate but not in nucleus accumbens. The binding of [125I]epidepride in the presence of 7-OH-DPAT (1000-fold selective for D3-like versus D2-like sites) and domperidone (20-fold selective for D2-like versus D3-like sites) was used to quantify the numbers of D2-like and D3-like receptors in areas of human brain. The distribution of D2-like and D3-like receptors was largely nonoverlapping. Binding of [125I]epidepride to D3-like receptors was negligible in the dorsal striatum but was concentrated in islands of dense binding in the nucleus accumbens and ventral putamen that aligned with acetylcholinesterase-poor striosomes. Binding to D3-like receptors was also enriched in the internal globus pallidus, ventral pallidum, septum, islands of Calleja, nucleus basalis, amygdalostriatal transition nucleus of the amygdala, central nucleus of the amygdala, and ventral tegmental area. Binding of [125I]epidepride to D2 but not D3 receptors was detected in cortex and hippocampus.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arai A., Black J., Lynch G. Origins of the variations in long-term potentiation between synapses in the basal versus apical dendrites of hippocampal neurons. Hippocampus. 1994 Feb;4(1):1–9. doi: 10.1002/hipo.450040103. [DOI] [PubMed] [Google Scholar]
- Besson M. J., Graybiel A. M., Nastuk M. A. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience. 1988 Jul;26(1):101–119. doi: 10.1016/0306-4522(88)90130-3. [DOI] [PubMed] [Google Scholar]
- Chio C. L., Lajiness M. E., Huff R. M. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol Pharmacol. 1994 Jan;45(1):51–60. [PubMed] [Google Scholar]
- Civelli O., Bunzow J. R., Grandy D. K., Zhou Q. Y., Van Tol H. H. Molecular biology of the dopamine receptors. Eur J Pharmacol. 1991 Aug 14;207(4):277–286. doi: 10.1016/0922-4106(91)90001-x. [DOI] [PubMed] [Google Scholar]
- Freedman S. B., Patel S., Marwood R., Emms F., Seabrook G. R., Knowles M. R., McAllister G. Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther. 1994 Jan;268(1):417–426. [PubMed] [Google Scholar]
- Gaspar P., Stepniewska I., Kaas J. H. Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J Comp Neurol. 1992 Nov 1;325(1):1–21. doi: 10.1002/cne.903250102. [DOI] [PubMed] [Google Scholar]
- Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J., Jr, Sibley D. R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990 Dec 7;250(4986):1429–1432. doi: 10.1126/science.2147780. [DOI] [PubMed] [Google Scholar]
- Graybiel A. M. Neurochemically specified subsystems in the basal ganglia. Ciba Found Symp. 1984;107:114–149. doi: 10.1002/9780470720882.ch7. [DOI] [PubMed] [Google Scholar]
- Jimenez-Castellanos J., Graybiel A. M. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience. 1987 Oct;23(1):223–242. doi: 10.1016/0306-4522(87)90285-5. [DOI] [PubMed] [Google Scholar]
- Joyce J. N., Janowsky A., Neve K. A. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J Pharmacol Exp Ther. 1991 Jun;257(3):1253–1263. [PubMed] [Google Scholar]
- Joyce J. N., Sapp D. W., Marshall J. F. Human striatal dopamine receptors are organized in compartments. Proc Natl Acad Sci U S A. 1986 Oct;83(20):8002–8006. doi: 10.1073/pnas.83.20.8002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lévesque D., Diaz J., Pilon C., Martres M. P., Giros B., Souil E., Schott D., Morgat J. L., Schwartz J. C., Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8155–8159. doi: 10.1073/pnas.89.17.8155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mach R. H., Luedtke R. R., Unsworth C. D., Boundy V. A., Nowak P. A., Scripko J. G., Elder S. T., Jackson J. R., Hoffman P. L., Evora P. H. 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. J Med Chem. 1993 Nov 12;36(23):3707–3720. doi: 10.1021/jm00075a028. [DOI] [PubMed] [Google Scholar]
- Mansour A., Meador-Woodruff J. H., Bunzow J. R., Civelli O., Akil H., Watson S. J. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci. 1990 Aug;10(8):2587–2600. doi: 10.1523/JNEUROSCI.10-08-02587.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGeer P. L., McGeer E. G., Suzuki J., Dolman C. E., Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology. 1984 Jun;34(6):741–745. doi: 10.1212/wnl.34.6.741. [DOI] [PubMed] [Google Scholar]
- McGonigle P., Neve K. A., Molinoff P. B. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct;30(4):329–337. [PubMed] [Google Scholar]
- Mogenson G. J., Yang C. R., Yim C. Y. Influence of dopamine on limbic inputs to the nucleus accumbens. Ann N Y Acad Sci. 1988;537:86–100. doi: 10.1111/j.1749-6632.1988.tb42098.x. [DOI] [PubMed] [Google Scholar]
- Murray A. M., Ryoo H., Joyce J. N. Visualization of dopamine D3-like receptors in human brain with [125I]epidepride. Eur J Pharmacol. 1992 Dec 1;227(4):443–445. doi: 10.1016/0922-4106(92)90164-q. [DOI] [PubMed] [Google Scholar]
- Rappaport M. S., Sealfon S. C., Prikhozhan A., Huntley G. W., Morrison J. H. Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum. Brain Res. 1993 Jul 9;616(1-2):242–250. doi: 10.1016/0006-8993(93)90215-9. [DOI] [PubMed] [Google Scholar]
- Schwartz J. C., Levesque D., Martres M. P., Sokoloff P. Dopamine D3 receptor: basic and clinical aspects. Clin Neuropharmacol. 1993 Aug;16(4):295–314. doi: 10.1097/00002826-199308000-00002. [DOI] [PubMed] [Google Scholar]
- Sokoloff P., Andrieux M., Besançon R., Pilon C., Martres M. P., Giros B., Schwartz J. C. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol. 1992 Apr 10;225(4):331–337. doi: 10.1016/0922-4106(92)90107-7. [DOI] [PubMed] [Google Scholar]
- Van Tol H. H., Bunzow J. R., Guan H. C., Sunahara R. K., Seeman P., Niznik H. B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991 Apr 18;350(6319):610–614. doi: 10.1038/350610a0. [DOI] [PubMed] [Google Scholar]